Skip to main content

Prescription Drugs, Heroin Use Increasing In Ohio

Prescription Drugs, Heroin Use Increasing In Ohio
The prescription drugs consumption are increasing which have become substances of choice for addicts.

According to Ohio state report there is a decrease in consumption with cocaine and methamphetamine use while the usage of prescription drug abuse is relatively high with an increased amount of heroin availability.


The state officials said that there main aim is to reduce the dishonor which is associated with addiction, no matter what the choice of drug is so as to prevent, treat and recover support services which would remain funded and accessible by anyone who needs them.

The maximum usage of drugs has been found in prescription drugs. Oxycodone, Hydrocodone, Xanax, Piperazine, Ritalin are the most commonly used prescription drugs in United States. Pills are a major problem with younger generation. The crime official authorities said that they are concerned about the growing usage of drugs such as Oxycodone and Oxycotin not just among youth but also adults.

When compared to Heroin usage from past six months it relatively has remained unchanged. Research is pointing to a marked decrease in crack and powder cocaine with all the regions. Once it is believed to be a drug of major concern it so much so important that several over-the-counter cold medications which involved the manufacture of behind the pharmacy counter like methamphetamine’s use is declining. In addition to restricting access to some of the chemicals which could be used to manufacture the drug, the report indicates that step up law enforcement would result in more meth labs being closed down.

The drug addiction department of Ohio provides information twice as year by interviewing active and recovering drug users, treatment professionals, law enforcement officers and crime lab personnel. This provides information to communities and policy makers to help them guide in the addiction, prevention, treatment and recovery services.

Comments